Abstract
AZD6140 100 and 200 mg bid were well tolerated and were superior to AZD6140 50 mg bid and clopidogrel 75 mg qd with regard to antiplatelet efficacy.
Keywords
ClopidogrelMedicineAspirinPharmacodynamicsP2Y12PharmacokineticsLoading doseDosingPlateletAntagonistPharmacologyAnesthesiaCrossover studyPlatelet aggregation inhibitorInternal medicinePlaceboReceptor
Affiliated Institutions
Related Publications
Pharmacology of CS-747 (prasugrel, LY640315), a Novel, Potent Antiplatelet Agent with in Vivo P2Y<sub>12</sub>Receptor Antagonist Activity
CS-747 (prasugrel, LY640315) is a member of the thienopyridine class of oral platelet aggregation inhibitors that includes ticlopidine and clopidogrel. A single oral administrat...
Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose
Background— Clopidogrel loading has mostly been studied in clopidogrel-naïve patients. Whether clopidogrel-treated patients readmitted for an acute coronary syndrome or percuta...
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
In aspirin-treated subjects with coronary artery disease, prasugrel 60/10 mg provides faster onset and greater inhibition of P2Y(12) receptor-mediated platelet aggregation than ...
Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits.
The possible activity of ticlopidine and its analogue clopidogrel in early atherogenesis was investigated. Incubation of rabbit platelets with the extracellular matrix produced ...
Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets
The aim of the study was to determine the effect of clopidogrel on adenosine diphosphate (ADP)- induced platelet activation in human volunteers. Platelets from human volunteers ...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 27
- Issue
- 9
- Pages
- 1038-1047
- Citations
- 734
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
734
OpenAlex
Cite This
Steen Husted,
Håkan Emanuelsson,
Stan Heptinstall
et al.
(2006).
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.
European Heart Journal
, 27
(9)
, 1038-1047.
https://doi.org/10.1093/eurheartj/ehi754
Identifiers
- DOI
- 10.1093/eurheartj/ehi754